The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAmidst a mixed earnings season for major corporations, US stocks exhibited divergent movements driven by financial reports and analyst rating adjustments. PepsiCo shares declined despite reporting Q2 sales and profit that exceeded expectations, suggesting investor caution regarding future guidance. Similarly, Salesforce stock dropped following a downgrade by KeyBanc, while Levi Strauss shares ticked upward after the company surpassed earnings estimates.
The decline in PepsiCo reflects broader caution in the consumer goods sector, as analysts compared its performance to Coca-Cola, which recently raised its annual forecasts (per Reuters reports). For Salesforce, the downgrade comes amid a general slowdown in cloud software spending, a trend that has also pressured peers like Microsoft and Oracle in recent months. Per market data, cost pressures continue to weigh on retail margins despite positive outliers like Levi Strauss.
Regarding current levels, Salesforce (CRM) stood at $162.5 at the close of July 9, 2026, while AstraZeneca (AZN) closed at $178.49. PepsiCo (PEP) was priced at $142.51 at the close of July 8, 2026. Traders are now looking toward upcoming US ISM Services PMI data, which may provide fresh signals on consumer spending strength and its impact on corporate earnings in the next quarter.